Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Sponsor

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

Germany Im Neuenheimer Feld 280, Neuenheim, 69120 Heidelberg, Germany

About the sponsor

Research activity includes early breast cancer with a focus on genomics, biomarker-guided therapy, and post-neoadjuvant treatment strategies in patients with high-risk disease.

  • Genomic profiling
  • Adjuvant systemic therapy
  • High-risk early breast cancer

The research landscape in this area centers on refining treatment selection after initial cancer therapy using molecular and clinical markers.

About Specializations

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts runs clinical trials in conditions such as Breast cancer, Non-small cell lung cancer, Colorectal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Breast cancer

Recruiting

Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

Non-small cell lung cancer

Not yet recruiting

Pembrolizumab alone versus pembrolizumab with chemotherapy drug combination in women with advanced non‑small cell lung cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

Colorectal cancer

Not recruiting

Study on Vitamin D3 and Glycerol for Reducing Fatigue in Colorectal Cancer Patients with Low Vitamin D Levels After Treatment

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.